μSPE followed by HPLC-MS/MS for the determination of series D and E resolvins in biological matrices

J Pharm Biomed Anal. 2021 Sep 5:203:114181. doi: 10.1016/j.jpba.2021.114181. Epub 2021 May 29.

Abstract

The critical role of acute inflammatory processes is recognized in many chronic diseases; a key point in molecular mechanisms of acute inflammation resolution is represented by a new group of pro-resolving lipid mediators that include distinct families of molecules: lipoxins, resolvins, protectins and maresins, collectively termed "specialized pro-resolving mediators" (SPMs). In particular, resolvins are active in the picogram to nanogram dose range, whereby they can directly modulate a plethora of anti-inflammatory responses. The presented method proposes an analytical protocol able to extract and to quantify 6 different resolvins from 3 different matrices (plasma, cells and exudates). The method, validated according to the EMA guideline for bioanalysis, exhibited good precision (1%-20%) and accuracy (2%-20%). In particular, the combination of two different sample preparation techniques, Liquid-Liquid Extraction (LLE) and micro-Solid Phase Extraction (μSPE), applied for the first on this class of molecules, used for the extraction and clean-up respectively, led to high enrichment factor (20 fold) and consequently a high sensitivity (LOQ between 1 and 38 pg mL-1); moreover the validation data proved the versatility of μSPE as clean-up tool as it was capable to manage huge enrichment factor without negatively affect accuracy and precision of analysis.

Keywords: Biological matrices; HPLC–MS/MS; Liquid-liquid extraction; Micro-SPE; Resolvins.

MeSH terms

  • Chromatography, High Pressure Liquid
  • Humans
  • Inflammation Mediators
  • Inflammation*
  • Solid Phase Extraction
  • Tandem Mass Spectrometry*

Substances

  • Inflammation Mediators